» Articles » PMID: 24462454

Three-dimensional Cell Culture Technique and Pathophysiology

Overview
Specialty Pharmacology
Date 2014 Jan 28
PMID 24462454
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Three-dimensional (3D) tissue constructs consisting of human cells have opened a new avenue for tissue engineering, pharmaceutical and pathophysiological applications, and have great potential to estimate the dynamic pharmacological effects of drug candidates, metastasis processes of cancer cells, and toxicity expression of nano-materials, as a 3D-human tissue model instead of in vivo animal experiments. However, most 3D-cellular constructs are a cell spheroid, which is a heterogeneous aggregation, and thus the reconstruction of the delicate and precise 3D-location of multiple types of cells is almost impossible. In recent years, various novel technologies to develop complex 3D-human tissues including blood and lymph capillary networks have demonstrated that physiological human tissue responses can be replicated in the nano/micro-meter ranges. Here, we provide a brief overview on current 3D-tissue fabrication technologies and their biomedical applications. 3D-human tissue models will be a powerful technique for pathophysiological applications.

Citing Articles

Multiorgan-on-a-chip for cancer drug pharmacokinetics-pharmacodynamics (PK-PD) modeling and simulations.

Mohammed A, Kurucaovali F, Okvur D J Pharmacokinet Pharmacodyn. 2024; 52(1):1.

PMID: 39630347 DOI: 10.1007/s10928-024-09955-2.


Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogels.

Majumder J, Torr E, Aisenbrey E, Lebakken C, Favreau P, Richards W J Tissue Eng. 2024; 15:20417314241230633.

PMID: 38361535 PMC: 10868488. DOI: 10.1177/20417314241230633.


Patient-derived organoids in human cancer: a platform for fundamental research and precision medicine.

Qu S, Xu R, Yi G, Li Z, Zhang H, Qi S Mol Biomed. 2024; 5(1):6.

PMID: 38342791 PMC: 10859360. DOI: 10.1186/s43556-023-00165-9.


Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery.

Fu J, Qiu H, Tan C Pharmaceutics. 2023; 15(4).

PMID: 37111785 PMC: 10141038. DOI: 10.3390/pharmaceutics15041300.


A Real-Time Sensing System for Monitoring Neural Network Degeneration in an Alzheimer's Disease-on-a-Chip Model.

Liu N, Liang C, Li Y, Lee I Pharmaceutics. 2022; 14(5).

PMID: 35631608 PMC: 9148060. DOI: 10.3390/pharmaceutics14051022.